Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression

Abstract Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide, is characterized by poor prognosis, high recurrence rates, and limited responsiveness to current therapies. Autophagy, a conserved catabolic pathway essential for cellular homeostasis, plays a paradoxical...

Full description

Saved in:
Bibliographic Details
Main Authors: Himanshi Goyal, Jyotdeep Kaur
Format: Article
Language:English
Published: Nature Publishing Group 2025-08-01
Series:Cell Death Discovery
Online Access:https://doi.org/10.1038/s41420-025-02667-7
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849333815834574848
author Himanshi Goyal
Jyotdeep Kaur
author_facet Himanshi Goyal
Jyotdeep Kaur
author_sort Himanshi Goyal
collection DOAJ
description Abstract Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide, is characterized by poor prognosis, high recurrence rates, and limited responsiveness to current therapies. Autophagy, a conserved catabolic pathway essential for cellular homeostasis, plays a paradoxical role in HCC, acting as a tumor suppressor during initiation but promoting survival and progression in advanced stages. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of autophagy, influencing tumorigenesis, metastasis, and therapy resistance through mechanisms such as miRNA sponging, chromatin remodeling, and protein interactions. This review describes how autophagy contributes to HCC at different stages, outlines the dual functions of lncRNAs as oncogenic drivers or tumor suppressors, and illustrates their integration into key signaling networks of autophagy (e.g., PI3K/AKT/mTOR, AMPK, Beclin-1). LncRNAs have been shown to modulate drug resistance, including resistance to first-line agents, by altering autophagic flux and associated molecular pathways. We also explored emerging strategies for targeting the lncRNA–autophagy axis, such as siRNAs, antisense oligonucleotides, and CRISPR/Cas systems, that have shown promise in preclinical studies and may be adapted for HCC. Furthermore, autophagy-related lncRNAs hold potential as non-invasive diagnostic and prognostic biomarkers and as predictors of recurrence. Integrating multi-omics approaches to validate these candidates will be critical for translation into clinical practice. Collectively, this review highlights the lncRNA–autophagy network as a promising frontier of biomarker discovery for precision diagnostics and targets for innovative therapeutics. The regulatory role of lncRNAs in autophagy presents a paradigm shift, heralding new strategies for targeted treatment.
format Article
id doaj-art-afecdf68d8c447e7be54e41a8d262db4
institution Kabale University
issn 2058-7716
language English
publishDate 2025-08-01
publisher Nature Publishing Group
record_format Article
series Cell Death Discovery
spelling doaj-art-afecdf68d8c447e7be54e41a8d262db42025-08-20T03:45:45ZengNature Publishing GroupCell Death Discovery2058-77162025-08-0111111410.1038/s41420-025-02667-7Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progressionHimanshi Goyal0Jyotdeep Kaur1Department of Biochemistry, Post Graduate Institute of Medical Education and ResearchDepartment of Biochemistry, Post Graduate Institute of Medical Education and ResearchAbstract Hepatocellular carcinoma (HCC), a leading cause of cancer-related mortality worldwide, is characterized by poor prognosis, high recurrence rates, and limited responsiveness to current therapies. Autophagy, a conserved catabolic pathway essential for cellular homeostasis, plays a paradoxical role in HCC, acting as a tumor suppressor during initiation but promoting survival and progression in advanced stages. Long non-coding RNAs (lncRNAs) have emerged as critical regulators of autophagy, influencing tumorigenesis, metastasis, and therapy resistance through mechanisms such as miRNA sponging, chromatin remodeling, and protein interactions. This review describes how autophagy contributes to HCC at different stages, outlines the dual functions of lncRNAs as oncogenic drivers or tumor suppressors, and illustrates their integration into key signaling networks of autophagy (e.g., PI3K/AKT/mTOR, AMPK, Beclin-1). LncRNAs have been shown to modulate drug resistance, including resistance to first-line agents, by altering autophagic flux and associated molecular pathways. We also explored emerging strategies for targeting the lncRNA–autophagy axis, such as siRNAs, antisense oligonucleotides, and CRISPR/Cas systems, that have shown promise in preclinical studies and may be adapted for HCC. Furthermore, autophagy-related lncRNAs hold potential as non-invasive diagnostic and prognostic biomarkers and as predictors of recurrence. Integrating multi-omics approaches to validate these candidates will be critical for translation into clinical practice. Collectively, this review highlights the lncRNA–autophagy network as a promising frontier of biomarker discovery for precision diagnostics and targets for innovative therapeutics. The regulatory role of lncRNAs in autophagy presents a paradigm shift, heralding new strategies for targeted treatment.https://doi.org/10.1038/s41420-025-02667-7
spellingShingle Himanshi Goyal
Jyotdeep Kaur
Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
Cell Death Discovery
title Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
title_full Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
title_fullStr Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
title_full_unstemmed Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
title_short Long non-coding RNAs and autophagy: dual drivers of Hepatocellular carcinoma progression
title_sort long non coding rnas and autophagy dual drivers of hepatocellular carcinoma progression
url https://doi.org/10.1038/s41420-025-02667-7
work_keys_str_mv AT himanshigoyal longnoncodingrnasandautophagydualdriversofhepatocellularcarcinomaprogression
AT jyotdeepkaur longnoncodingrnasandautophagydualdriversofhepatocellularcarcinomaprogression